Background: The progression of head and neck squamous cell carcinoma (HN-SCC) is sometimes rapid. It is well known that, for a good prognosis, it is critical to avoid a delay in initiating radiation therapy for HN-SCC.
Objectives: We defined the waiting period as the duration between the date of first visit to the medical institution and the date of treatment initiation. Additionally, we determined the impacts of factors affecting the starting period of radiation therapy.
Materials and Methods: The population data were retrospectively sourced from medical charts involving 49 HN-SCC patients with a median waiting period of 38 days who underwent new radiation therapy or chemoradiation therapy at our department from April 1, 2017 to March 31, 2019.
Results: Mainly, the waiting period (38 days) and the duration between a pathologically confirmed diagnosis and the initiation of radiotherapy (26 days) for HN-SCC were both significantly shorter than those found previously in other related studies. When the primary lesion was the hypopharynx, the waiting period for treatment was longer than that of the oropharynx and larynx. Additionally, although there was no statistical difference, the cases first detected in the ENT department were shorter than those first detected in other departments.
Conclusion: The waiting period for HN-SCC was significantly shorter than those found previously in other related studies. The detection and diagnosis of hypopharyngeal cancer tend to be delayed, so careful attention is required. We believe that it is necessary to encourage, through public awareness activities, patients to consult an ENT department when there are symptoms suggestive of head and neck cancer.
View full abstract